Literature DB >> 16787282

RNA Interference with chemically modified siRNA.

Hong-Yan Zhang1, Quan Du, Claes Wahlestedt, Zicai Liang.   

Abstract

siRNA has become an indispensable tool for functional characterization of genes. It has also demonstrated tremendous potential as a new generation of drug candidates. Although the technology works very well to a great panel of cells in vitro, it is still a challenge to translate the success into in vivo target validation easiness and, even more difficult, into therapeutic applications. With a number of chemically modified compounds under initial clinical trial from several commercial entities, the interests in chemical modification of siRNA have become heightened. In this review we have tried to touch on most of the chemical modifications of RNA that have been tested in the siRNA landscape, but maintained a focus on the backbone modifications, and 2'-modifications on the ribose ring. It is anticipated that more modifications and more systematic comparisons between different modifications will be performed to draw more educated conclusions over some of the modifications.

Mesh:

Substances:

Year:  2006        PMID: 16787282     DOI: 10.2174/156802606777303676

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  10 in total

1.  Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs.

Authors:  Michael A Collingwood; Scott D Rose; Lingyan Huang; Chris Hillier; Mohammad Amarzguioui; Merete T Wiiger; Harris S Soifer; John J Rossi; Mark A Behlke
Journal:  Oligonucleotides       Date:  2008-06

2.  Chemical modification resolves the asymmetry of siRNA strand degradation in human blood serum.

Authors:  John A H Hoerter; Nils G Walter
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

3.  Combinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery.

Authors:  Kerry P Mahon; Kevin T Love; Kathryn A Whitehead; June Qin; Akin Akinc; Elizaveta Leshchiner; Ignaty Leshchiner; Robert Langer; Daniel G Anderson
Journal:  Bioconjug Chem       Date:  2010-08-18       Impact factor: 4.774

4.  Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.

Authors:  Qing Ge; Anne Dallas; Heini Ilves; Joshua Shorenstein; Mark A Behlke; Brian H Johnston
Journal:  RNA       Date:  2009-11-30       Impact factor: 4.942

5.  Stability study of unmodified siRNA and relevance to clinical use.

Authors:  Robyn P Hickerson; Alexander V Vlassov; Qian Wang; Devin Leake; Heini Ilves; Emilio Gonzalez-Gonzalez; Christopher H Contag; Brian H Johnston; Roger L Kaspar
Journal:  Oligonucleotides       Date:  2008-12

6.  Improving model predictions for RNA interference activities that use support vector machine regression by combining and filtering features.

Authors:  Andrew S Peek
Journal:  BMC Bioinformatics       Date:  2007-06-06       Impact factor: 3.169

7.  RNA interference in mammalia cells by RNA-3'-PNA chimeras.

Authors:  Nicoletta Potenza; Loredana Moggio; Giovanna Milano; Vincenzo Salvatore; Benedetto Di Blasio; Aniello Russo; Anna Messere
Journal:  Int J Mol Sci       Date:  2008-03-12       Impact factor: 6.208

8.  Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery.

Authors:  Mousa Jafari; Wen Xu; Ran Pan; Chad M Sweeting; Desiree Nedra Karunaratne; Pu Chen
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

Review 9.  Achieving HIV-1 Control through RNA-Directed Gene Regulation.

Authors:  Vera Klemm; Jye Mitchell; Christina Cortez-Jugo; Francesca Cavalieri; Geoff Symonds; Frank Caruso; Anthony Dominic Kelleher; Chantelle Ahlenstiel
Journal:  Genes (Basel)       Date:  2016-12-07       Impact factor: 4.096

Review 10.  RNA interference: from basic research to therapeutic applications.

Authors:  Jens Kurreck
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.